The Immunobiology of SARS*.
Identifieur interne : 003581 ( Main/Exploration ); précédent : 003580; suivant : 003582The Immunobiology of SARS*.
Auteurs : Jun Chen [États-Unis] ; Kanta SubbaraoSource :
- Annual review of immunology [ 0732-0582 ] ; 2007.
Descripteurs français
- KwdFr :
- Animaux, Anticorps antiviraux (immunologie), Chimiokines (immunologie), Humains, Inflammation (immunologie), Interféron de type I (immunologie), Lectines de type C (immunologie), Modèles animaux de maladie humaine, Molécules d'adhérence cellulaire (immunologie), Peptidyl-Dipeptidase A (immunologie), Récepteurs de surface cellulaire (immunologie), Spécificité d'organe, Syndrome respiratoire aigu sévère (immunologie), Virus du SRAS (immunologie).
- MESH :
- immunologie : Anticorps antiviraux, Chimiokines, Inflammation, Interféron de type I, Lectines de type C, Molécules d'adhérence cellulaire, Peptidyl-Dipeptidase A, Récepteurs de surface cellulaire, Syndrome respiratoire aigu sévère, Virus du SRAS.
- Animaux, Humains, Modèles animaux de maladie humaine, Spécificité d'organe.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (immunology), Cell Adhesion Molecules (immunology), Chemokines (immunology), Disease Models, Animal, Humans, Inflammation (immunology), Interferon Type I (immunology), Lectins, C-Type (immunology), Organ Specificity, Peptidyl-Dipeptidase A (immunology), Receptors, Cell Surface (immunology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology).
- MESH :
- chemical , immunology : Antibodies, Viral, Cell Adhesion Molecules, Chemokines, Interferon Type I, Lectins, C-Type, Peptidyl-Dipeptidase A, Receptors, Cell Surface.
- immunology : Inflammation, SARS Virus, Severe Acute Respiratory Syndrome.
- Animals, Disease Models, Animal, Humans, Organ Specificity.
Abstract
Severe acute respiratory syndrome (SARS) presented as an atypical pneumonia that progressed to acute respiratory distress syndrome in approximately 20% of cases and was associated with a mortality of about 10%. The etiological agent was a novel coronavirus (CoV). Angiotensin-converting enzyme 2 is the functional receptor for SARS-CoV; DC-SIGN and CD209L (L-SIGN) can enhance viral entry. Although the virus infects the lungs, gastrointestinal tract, liver, and kidneys, the disease is limited to the lungs, where diffuse alveolar damage is accompanied by a disproportionately sparse inflammatory infiltrate. Pro-inflammatory cytokines and chemokines, particularly IP-10, IL-8, and MCP-1, are elevated in the lungs and peripheral blood, but there is an unusual lack of an antiviral interferon (IFN) response. The virus is susceptible to exogenous type I IFN but suppresses the induction of IFN. Innate immunity is important for viral clearance in the mouse model. Virus-specific neutralizing antibodies that develop during convalescence prevent reinfection in animal models.
DOI: 10.1146/annurev.immunol.25.022106.141706
PubMed: 17243893
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001F16
- to stream PubMed, to step Curation: 001F16
- to stream PubMed, to step Checkpoint: 001C70
- to stream Ncbi, to step Merge: 001845
- to stream Ncbi, to step Curation: 001845
- to stream Ncbi, to step Checkpoint: 001845
- to stream Main, to step Merge: 003694
- to stream Main, to step Curation: 003581
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Immunobiology of SARS*.</title>
<author><name sortKey="Chen, Jun" sort="Chen, Jun" uniqKey="Chen J" first="Jun" last="Chen">Jun Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland 20892, USA. chenju@niaid.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland 20892</wicri:regionArea>
<wicri:noRegion>Maryland 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17243893</idno>
<idno type="pmid">17243893</idno>
<idno type="doi">10.1146/annurev.immunol.25.022106.141706</idno>
<idno type="wicri:Area/PubMed/Corpus">001F16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F16</idno>
<idno type="wicri:Area/PubMed/Curation">001F16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C70</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C70</idno>
<idno type="wicri:Area/Ncbi/Merge">001845</idno>
<idno type="wicri:Area/Ncbi/Curation">001845</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001845</idno>
<idno type="wicri:doubleKey">0732-0582:2007:Chen J:the:immunobiology:of</idno>
<idno type="wicri:Area/Main/Merge">003694</idno>
<idno type="wicri:Area/Main/Curation">003581</idno>
<idno type="wicri:Area/Main/Exploration">003581</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Immunobiology of SARS*.</title>
<author><name sortKey="Chen, Jun" sort="Chen, Jun" uniqKey="Chen J" first="Jun" last="Chen">Jun Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland 20892, USA. chenju@niaid.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland 20892</wicri:regionArea>
<wicri:noRegion>Maryland 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name>
</author>
</analytic>
<series><title level="j">Annual review of immunology</title>
<idno type="ISSN">0732-0582</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Cell Adhesion Molecules (immunology)</term>
<term>Chemokines (immunology)</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Inflammation (immunology)</term>
<term>Interferon Type I (immunology)</term>
<term>Lectins, C-Type (immunology)</term>
<term>Organ Specificity</term>
<term>Peptidyl-Dipeptidase A (immunology)</term>
<term>Receptors, Cell Surface (immunology)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Chimiokines (immunologie)</term>
<term>Humains</term>
<term>Inflammation (immunologie)</term>
<term>Interféron de type I (immunologie)</term>
<term>Lectines de type C (immunologie)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Molécules d'adhérence cellulaire (immunologie)</term>
<term>Peptidyl-Dipeptidase A (immunologie)</term>
<term>Récepteurs de surface cellulaire (immunologie)</term>
<term>Spécificité d'organe</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Cell Adhesion Molecules</term>
<term>Chemokines</term>
<term>Interferon Type I</term>
<term>Lectins, C-Type</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Receptors, Cell Surface</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Chimiokines</term>
<term>Inflammation</term>
<term>Interféron de type I</term>
<term>Lectines de type C</term>
<term>Molécules d'adhérence cellulaire</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Récepteurs de surface cellulaire</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Inflammation</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Organ Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Spécificité d'organe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) presented as an atypical pneumonia that progressed to acute respiratory distress syndrome in approximately 20% of cases and was associated with a mortality of about 10%. The etiological agent was a novel coronavirus (CoV). Angiotensin-converting enzyme 2 is the functional receptor for SARS-CoV; DC-SIGN and CD209L (L-SIGN) can enhance viral entry. Although the virus infects the lungs, gastrointestinal tract, liver, and kidneys, the disease is limited to the lungs, where diffuse alveolar damage is accompanied by a disproportionately sparse inflammatory infiltrate. Pro-inflammatory cytokines and chemokines, particularly IP-10, IL-8, and MCP-1, are elevated in the lungs and peripheral blood, but there is an unusual lack of an antiviral interferon (IFN) response. The virus is susceptible to exogenous type I IFN but suppresses the induction of IFN. Innate immunity is important for viral clearance in the mouse model. Virus-specific neutralizing antibodies that develop during convalescence prevent reinfection in animal models.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Chen, Jun" sort="Chen, Jun" uniqKey="Chen J" first="Jun" last="Chen">Jun Chen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003581 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003581 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:17243893 |texte= The Immunobiology of SARS*. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17243893" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |